Brief: BD, CerTest Biotec Announce U.S. Commercial Launch Of Monkeypox Assay
26/09/2022 11:56
Sept 26 (Reuters) - Becton Dickinson and Co BDX.N :
* BD, CERTEST BIOTEC ANNOUNCE US COMMERCIAL LAUNCH OF
MONKEYPOX
ASSAY
Source text for Eikon: ID:nPn7q3dY8a
Further company coverage: BDX.N
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Becton Dickinson and Co
See all newsCorrected: BDx secures data center power contract from Indonesia's PLN
China's commerce ministry holds meeting with foreign pharmaceutical firms
Brief: Becton Dickinson Euro Finance S.À R.L Files For Euro-Denominated 600 Million 3.855% Notes Offering Due 2033 - SEC Filing
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
Becton Dickinson raises 2026 profit forecast on drug delivery devices demand (updated)